ResearchBib Share Your Research, Maximize Your Social Impacts
Sign for Notice Everyday Sign up >> Login

Biotech 2012 - Managing Immunogenicity Risk in Biopharmaceuticals

Date2012-03-08

Deadline2012-03-08

VenuePalo Alto, USA - United States USA - United States

KeywordsImmunogenicity Risk Regulations; Immunogenicity Risk training; biopharmaceutical regulations compliance; biopharmaceutical development programs; biopharmaceutical drug development

Websitehttp://www.complianceonline.com/ecommerc...

Topics/Call fo Papers

This Immunogenicity risk training Webinar will help you understand immunogenicity and analyzing risk factors to strategically develop biopharmaceuticals.
Why Should You Attend:
This presentation begins with an overview of the biological self versus non-self mechanism resulting in the anti-drug response of biopharmaceuticals. The next section describes how to differentiate the risk associated with internal attributes of the drug from the risk derived from external factors. That guideline in conjunction with the latest industry recommendations and regulatory guidelines provides a logical approach to the risk strategy.
Areas Covered in the seminar:
This presentation reviews the following important topics to understand immunogenicity and analyzing risk factors to strategically develop biopharmaceuticals:
- Self versus non-self.
- Risk factors associated with immunogenicity.
- Regulatory expectations on immunogenicity testing .
- How to use immunogenicity results from pre-clinical studies.
- Minimizing immunogenicity risk.
- Phase specific sampling plan.
- Case study and commercialization strategy.

Last modified: 2011-12-08 20:14:09